# Jiangsu Beilian Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-beilian-biotechnology-co

- Industry: Biotechnology
- Headquarters: Changzhou, China
- Latest round: Angel (Jul 2, 2026)
- Investors on record: 1

## About

Based in Changzhou, China and founded in 2026, Jiangsu Beilian Biotechnology Co., Ltd. is a company focused on the research and development of innovative biopharmaceuticals. In July 2026, Jiangsu Beilian Biotechnology Co., Ltd. raised an angel funding from Hengxu Capital.

The company primarily engages in the research and industrialization of antibody-drug conjugates (ADCs) and related novel antibody technology platforms, and utilizes novel antibody engineering, linker, and highly active payload technologies to develop innovative therapies for major diseases such as cancer.

The company will use the funding to support its research and development and industrialization of antibody-drug conjugates (ADCs) and related novel antibody technology platforms.

## Funding rounds

- Angel, Jul 2, 2026 — Hengxu Capital

## Investors

- Hengxu Capital (https://capitalatlas.ai/funds/hengxu-capital) — Angel